Dr. Howard Smith Oncall

  Vidcast:  https://youtu.be/mFT9bvU8Zng   Drugs in the proton pump inhibitor (PPI) family negatively impact the memory and thought processing of breast cancer survivors by a factor of 20 to nearly 30%.  This the conclusion of an Ohio State University behavioral medicine study of some 88 patients.   PPI users reported 20% more difficulties concentrating and 28% more impaired memory.  Users of these drugs including Prevacid, Nexium, and Prilosec, all available over-the-counter, complained about lower quality of life and day-to-day problem solving difficulties.   The FDA only approved PPIs for short-term use.  Breast cancer survivors and all of use should minimize their use.  Don’t forget the safe alternative: good old antacid Tums.   Annelise A. Madison, Alex Woody, Brittney Bailey, Maryam B. Lustberg, Bhuvaneswari Ramaswamy, Robert Wesolowski, Nicole Williams, Raquel Reinbolt, Jeffrey B. VanDeusen, Sagar Sardesai, William B. Malarkey, Janice K. Kiecolt-Glaser. Cognitive problems of breast cancer survivors on